Who
Renee Gaeta
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Outset Medical; Director, Candel Therapeutics; Chief Financial Officer, Shockwave Medical; Director, SeaSpine Holdings; Chief Financial Officer, Establishment Labs Holdings.
In numbers
- Trades disclosed
- 47
- Buys
- 0
- Sells
- 11
- Bought
- $0
- Sold
- $1.1M
- Companies
- 5
- Companies where not an officer
- 2
- First trade
- 19 Feb 2019
- Last trade
- 17 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Aug 2026filed 18 Aug 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Sold | $20K4,543 at $4.39 | filing |
| 17 Aug 2026filed 18 Aug 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Sold | $20K4,543 at $4.39 | filing |
| 26 Jun 2026filed 29 Jun 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Code A | —71,630 at $0.00 | filing |
| 26 Jun 2026filed 29 Jun 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Code A | —71,630 at $0.00 | filing |
| 23 Jun 2026filed 24 Jun 2026 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,000 at $0.00 | filing |
| 23 Jun 2026filed 24 Jun 2026 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,000 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Sold | $87K17,672 at $4.94 | filing |
| 3 Jun 2026filed 5 Jun 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Sold | $87K17,672 at $4.94 | filing |
| 17 Jun 2025filed 18 Jun 2025 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,240 at $0.00 | filing |
| 10 Jun 2025filed 11 Jun 2025 | OM Outset MedicalMedical Devices | SEC FORM 4 Code A | —131,425 at $0.00 | filing |
| 26 Jun 2024filed 27 Jun 2024 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,240 at $0.00 | filing |
| 31 May 2024filed 31 May 2024 | Shockwave Medical | SEC FORM 4 Code D | —19,890 | filing |
| 5 Feb 2024filed 6 Feb 2024 | Shockwave Medical | SEC FORM 4 Code A | —19,890 at $0.00 | filing |
| 28 Jun 2023filed 29 Jun 2023 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,240 at $0.00 | filing |
| 5 Jan 2023filed 9 Jan 2023 | SeaSpine Holdings | SEC FORM 4 Code D | —36,056 | filing |
| 8 Aug 2022filed 10 Aug 2022 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —28,480 at $0.00 | filing |
| 1 Jun 2022filed 3 Jun 2022 | SeaSpine Holdings | SEC FORM 4 Code A | —15,943 at $0.00 | filing |
| 14 Mar 2022filed 15 Mar 2022 | SeaSpine Holdings | SEC FORM 4 Sold | $24K2,000 at $12.03 | filing |
| 14 Feb 2022filed 16 Feb 2022 | SeaSpine Holdings | SEC FORM 4 Sold | $24K2,000 at $12.06 | filing |
| 10 Jan 2022filed 10 Jan 2022 | SeaSpine Holdings | SEC FORM 4 Sold | $25K2,000 at $12.35 | filing |
News
Outset Medical (NASDAQ:OM) vs. InspireMD (NYSE:NSPR) Financial ComparisonOM · tickerreport.com · 21 Oct 2026Head-To-Head Contrast: Femasys (NASDAQ:FEMY) versus Outset Medical (NASDAQ:OM)OM · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Renee Gaeta; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.